BioVie Inc (BIVI)
0.4862
-0.01
(-2.25%)
USD |
NASDAQ |
May 10, 16:00
0.4862
0.00 (0.00%)
After-Hours: 20:00
BioVie Cash from Financing (TTM): 15.36M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.36M |
September 30, 2023 | 42.97M |
June 30, 2023 | 55.37M |
March 31, 2023 | 54.10M |
December 31, 2022 | 44.34M |
September 30, 2022 | 26.42M |
June 30, 2022 | 33.12M |
March 31, 2022 | 33.29M |
December 31, 2021 | 33.81M |
September 30, 2021 | 19.20M |
June 30, 2021 | 14.93M |
March 31, 2021 | 15.15M |
December 31, 2020 | 15.04M |
September 30, 2020 | 15.07M |
June 30, 2020 | 1.326M |
March 31, 2020 | 0.932M |
December 31, 2019 | 0.53M |
September 30, 2019 | 0.764M |
June 30, 2019 | 2.796M |
March 31, 2019 | 3.023M |
Date | Value |
---|---|
December 31, 2018 | 3.098M |
September 30, 2018 | 2.974M |
June 30, 2018 | 0.662M |
March 31, 2018 | 0.53M |
December 31, 2017 | 0.7545M |
September 30, 2017 | 0.712M |
June 30, 2017 | 0.505M |
March 31, 2017 | 0.41M |
December 31, 2016 | 0.1105M |
September 30, 2016 | 0.013M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.53M
Minimum
Dec 2019
55.37M
Maximum
Jun 2023
22.34M
Average
15.36M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
Adial Pharmaceuticals Inc | 4.132M |
Precision BioSciences Inc | 5.387M |
Cardiff Oncology Inc | 0.107M |
Jaguar Health Inc | 34.23M |
First Wave BioPharma Inc | 15.23M |